Articles published by INmune Bio, Inc.
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
June 27, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio Inc. to Join Russell 3000® Index
May 30, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 25, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
March 05, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 12, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
February 06, 2024
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
November 15, 2023
From INmune Bio, Inc.
Via GlobeNewswire
Tickers
INMB
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.